| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |